Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Beginning Cash Balance (2022 - 2023)

Bioregenx (BRGX) has 2 years of Beginning Cash Balance data on record, last reported at $190891.0 in Q4 2023.

  • For Q4 2023, Beginning Cash Balance rose 27170.14% year-over-year to $190891.0; the TTM value through Mar 2024 reached $18001.0, down 37.86%, while the annual FY2023 figure was $191001.0, 27185.86% up from the prior year.
  • Beginning Cash Balance reached $190891.0 in Q4 2023 per BRGX's latest filing, up from -$172890.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $190891.0 in Q4 2023 and bottomed at -$172890.0 in Q2 2023.